Clinical Trial

An Online Lifestyle Program With an AI Lifestyle Coach and Continues Glucose Monitoring in Type 2 Diabetes.

Study acronym: PREVAIL
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this study is to evaluate the feasibility and effectiveness of a remote personalised lifestyle program in individuals with T2D. Outcomes will be assessed at the start and after 3, 6, and 12 months with two follow-up measurements (18 and 24 months) to determine whether participation in this re-mote lifestyle program leads to improvements in health and diabetes-related outcomes.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-16.
Trial Details
NCT Number NCT07661381
Lead Sponsor University of Twente
Collaborators: TNO
Conditions Diabetes Type 2
Enrollment 160 participants
Start Date 2026-09
Primary Completion 2028-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-25